Clinical Trials
25
Active:0
Completed:24
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Home Retinal Imaging Using NOTAL-OCT V3.0
Completed
- Conditions
- A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF Treatment
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Notal Vision Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT04241198
- Locations
- 🇮🇱
TLV Medical Center, Tel Aviv, Israel
Retinal Imaging Using NOTAL-OCT V3.0
Not Applicable
Completed
- Conditions
- DRAMD
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Notal Vision Ltd.
- Target Recruit Count
- 58
- Registration Number
- NCT04078672
- Locations
- 🇮🇱
Assuta Hashalom, Tel Aviv, Israel
🇮🇱Tel Aviv Medical Center, Tel Aviv, Israel
NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients
Completed
- Conditions
- AMD - Age-Related Macular DegenerationDiabetic Macular Edema
- First Posted Date
- 2019-05-31
- Last Posted Date
- 2020-11-12
- Lead Sponsor
- Notal Vision Ltd.
- Target Recruit Count
- 287
- Registration Number
- NCT03969303
- Locations
- 🇺🇸
Elman Retina Group, PA, Baltimore, Maryland, United States
Retinal Imaging Using NOTAL-OCT V2.5
Completed
- Conditions
- AMD
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Notal Vision Ltd.
- Target Recruit Count
- 87
- Registration Number
- NCT03600519
- Locations
- 🇮🇱
Bnei Zion, Haifa, Israel
Retinal Imaging Using NOTAL-OCT
Completed
- Conditions
- Diabetic RetinopathyAge-Related Macular Degeneration
- First Posted Date
- 2017-12-14
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Notal Vision Ltd.
- Target Recruit Count
- 33
- Registration Number
- NCT03374020
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found